Evogene Ltd. (TLV:EVGN)
399.00
-2.00 (-0.50%)
Oct 5, 2025, 3:49 PM IDT
Evogene Revenue
Evogene had revenue of $884.00K USD in the quarter ending June 30, 2025, a decrease of -3.28%. This brings the company's revenue in the last twelve months to $9.44M, down -0.05% year-over-year. In the year 2024, Evogene had annual revenue of $8.51M with 50.90% growth.
Revenue (ttm)
$9.44M
Revenue Growth
-0.05%
P/S Ratio
1.10
Revenue / Employee
$80.72K
Employees
117
Market Cap
34.95M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.51M | 2.87M | 50.90% |
Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 56.02B |
Danel (Adir Yeoshua) | 2.84B |
Kamada | 571.15M |
Bait Bakfar | 106.25M |
BrainsWay | 155.27M |
SofWave Medical | 234.12M |
Ilex Medical | 927.57M |
Novolog (Pharm-Up 1966) | 2.04B |
Evogene News
- 5 weeks ago - Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York - PRNewsWire
- 7 weeks ago - Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Evogene GAAP EPS of -$0.85 misses by $0.22, revenue of $0.88M misses by $0.05M - Seeking Alpha
- 7 weeks ago - Evogene Reports Second Quarter 2025 Financial Results - PRNewsWire
- 7 weeks ago - Evogene Q2 2025 Earnings Preview - Seeking Alpha
- 7 weeks ago - Preview: Evogene's Earnings - Benzinga
- 2 months ago - Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - PRNewsWire
- 2 months ago - Evogene Schedules Second Quarter 2025 Financial Results Release - PRNewsWire